A detailed history of Maryland Capital Advisors Inc. transactions in Organon & Co. stock. As of the latest transaction made, Maryland Capital Advisors Inc. holds 250 shares of OGN stock, worth $4,462. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 250 -0.0%
Holding current value
$4,462
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$30.45 - $39.36 $395 - $511
-13 Reduced 4.94%
250 $9,000
Q4 2021

Feb 01, 2022

BUY
$28.67 - $37.13 $7,540 - $9,765
263 New
263 $8,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.54B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Maryland Capital Advisors Inc. Portfolio

Follow Maryland Capital Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland Capital Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Maryland Capital Advisors Inc. with notifications on news.